Lilly Faces First Week of “Bellwether” Cymbalta Withdrawal Lawsuit

Kermit Cole
0
219
Calling it “Poison,” plaintiff Claudia Herrera testified she would not have taken Eli Lilly’s drug Cymbalta had she known the risks. Lilly hid the risks of withdrawal symptoms such as electric-like “zaps,” anxiety, spasms, and suicidal ideation, Herrera lawsuit claims, alleging that nearly half of users experience withdrawal rather than the 1% Lilly claims.
Eli Lilly faces first U.S. trials over Cymbalta withdrawal (Reuters)
Previous articleThe Ubiquity of Unhappiness: An Introduction to Cultural Psychiatry
Next articleThoughts on the Nature of Emotions
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected]